. Author manuscript; available in PMC: 2020 Mar 1.

Published in final edited form as: J Thorac Oncol. 2018 Dec 18;14(3):377–407. doi: 10.1016/j.jtho.2018.12.005

Table 4.

Results of TTF1 expression in tumors from primary sites including female genital tract, breast, colon and stomach in some of the published studies in the literature (reproduced from Ordonez NG. Value of thyroid transcription factor −1 immunostaining in tumor diagnosis: a review and update. Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):4429–44).

	8G7G3/1		SPT24
	n=	positive (%)	n=	positive (%)
Ovarian carcinoma	615	22 (3.6%)	161	16 (9.9%)
Endometrial adenocarcinoma	215	17 (7.9%)	68	19 (27.9%)
Uterine cervical adenocarcinoma	92	3 (3.3%)	39	6 (15.4%breast)
Uterine cervical squamous carcinoma	7	0 (0%)
Breast adenocarcinoma	297	4 (1.5%)	580	13 (2.4%)
Colon adenocarcinoma	594	11 (1.8%)	258	15 (5.8%)
Gastric adenocarcinoma	170	3 (1.8%)	110	1 (0.9%)